These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 31304962)

  • 1. Cardiovascular long-term outcome and prophylactic treatment patterns in peripheral arterial disease in a population-based cohort.
    Sartipy F; Lundin F; Wahlberg E; Sigvant B
    Eur Heart J Qual Care Clin Outcomes; 2019 Oct; 5(4):310-320. PubMed ID: 31304962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome.
    Sartipy F; Sigvant B; Lundin F; Wahlberg E
    Eur J Vasc Endovasc Surg; 2018 Apr; 55(4):529-536. PubMed ID: 29478910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial Disease.
    Sigvant B; Lundin F; Wahlberg E
    Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):395-403. PubMed ID: 26777541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of asymptomatic Peripheral Arterial Disease in combination with common risk factors elevates the cardiovascular risk Substantially.
    Sartipy F; Garcia Pereira Filho AJ; Lundin F; Wahlberg E; Sigvant B
    Int J Cardiol Cardiovasc Risk Prev; 2022 Jun; 13():200130. PubMed ID: 35493293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
    Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial infarction and peripheral arterial disease: Treatment patterns and long-term outcome in men and women results from a Swedish nationwide study.
    Sigvant B; Hasvold P; Thuresson M; Jernberg T; Janzon M; Nordanstig J
    Eur J Prev Cardiol; 2021 Oct; 28(13):1426-1434. PubMed ID: 34695221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease.
    Urbonaviciene G; Martin-Ventura JL; Lindholt JS; Urbonavicius S; Moreno JA; Egido J; Blanco-Colio LM
    Atherosclerosis; 2011 Dec; 219(2):892-9. PubMed ID: 21962403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease.
    Diehm C; Allenberg JR; Pittrow D; Mahn M; Tepohl G; Haberl RL; Darius H; Burghaus I; Trampisch HJ;
    Circulation; 2009 Nov; 120(21):2053-61. PubMed ID: 19901192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic cerebral infarction is a predictor of long-term survival and vascular or limb events in peripheral arterial disease.
    Kumakura H; Kanai H; Matsuo Y; Iwasaki T; Ichikawa S
    Eur Heart J Qual Care Clin Outcomes; 2019 Jan; 5(1):43-50. PubMed ID: 29931172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic usefulness of clinical and subclinical peripheral arterial disease in men with stable coronary heart disease.
    Bouisset F; Bongard V; Ruidavets JB; Hascoët S; Taraszkiewicz D; Roncalli J; Carrié D; Galinier M; Elbaz M; Ferrières J
    Am J Cardiol; 2012 Jul; 110(2):197-202. PubMed ID: 22513182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes.
    Mueller T; Hinterreiter F; Luft C; Poelz W; Haltmayer M; Dieplinger B
    J Vasc Surg; 2014 May; 59(5):1291-9. PubMed ID: 24393280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality--the CAVASIC Study.
    Pohlhammer J; Kronenberg F; Rantner B; Stadler M; Peric S; Hammerer-Lercher A; Klein-Weigel P; Fraedrich G; Kollerits B
    Atherosclerosis; 2014 Dec; 237(2):711-7. PubMed ID: 25463110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-Year Follow-Up of Vascular Events in Peripheral Arterial Disease Treated With Antiplatelet Agents: A Prospective Observational Multicenter Cohort Study (SEASON).
    Higashi Y; Miyata T; Shigematsu H; Origasa H; Fujita M; Matsuo H; Naritomi H; Matsuda H; Nakajima M; Awano H
    Sci Rep; 2017 Jul; 7(1):6095. PubMed ID: 28733607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients.
    Höbaus C; Tscharre M; Herz CT; Pesau G; Wrba T; Koppensteiner R; Schernthaner GH
    Atherosclerosis; 2018 Jul; 274():152-156. PubMed ID: 29783062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease.
    Martinez-Aguilar E; Gomez-Rodriguez V; Orbe J; Rodriguez JA; Fernández-Alonso L; Roncal C; Páramo JA
    J Vasc Surg; 2015 Feb; 61(2):428-35. PubMed ID: 25441671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of relationship between gait parameters and physical function in peripheral arterial disease.
    Scherer SA; Hiatt WR; Regensteiner JG
    J Vasc Surg; 2006 Oct; 44(4):782-8. PubMed ID: 17012002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Cilostazol Therapy in Hemodialysis Patients with Asymptomatic Peripheral Arterial Disease: A Retrospective Cohort Study.
    Lim PS; Jeng Y; Wu MY; Pai MA; Wu TK; Chen CH
    Biomed Res Int; 2016; 2016():8236903. PubMed ID: 27747241
    [No Abstract]   [Full Text] [Related]  

  • 19. Abnormally High Ankle-Brachial Index is Associated with All-cause and Cardiovascular Mortality: The REGICOR Study.
    Velescu A; Clara A; Martí R; Ramos R; Perez-Fernandez S; Marcos L; Grau M; Degano IR; Marrugat J; Elosua R
    Eur J Vasc Endovasc Surg; 2017 Sep; 54(3):370-377. PubMed ID: 28754427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of ischemic events in patients with peripheral arterial disease design, baseline characteristics and 2-year results an observational study.
    Blinc A; Kozak M; Sabovic M; Božic M; Stegnar M; Poredoš P; Kravos A; Barbic-Žagar B; Pohar Perme M; Stare J;
    Int Angiol; 2011 Dec; 30(6):555-66. PubMed ID: 22233617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.